Develops drugs for rare diseases.
Mar 2025Revenue ¥4.58T/yrExpenses ¥4.24T/yr
No trend
Figures by year
Is Takeda Pharmaceutical profitable?
Yes. In the 12 months to Mar 2025, revenue was ¥4.58T and expenses ¥4.24T.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2025 | ¥4.58T | ¥4.24T | ¥343B |
| Mar 2024 | ¥4.26T | ¥4.05T | ¥214B |
| Mar 2023 | ¥4.03T | ¥3.54T | ¥491B |
| Mar 2022 | ¥3.57T | ¥3.11T | ¥461B |
| Mar 2021 | ¥3.20T | ¥2.69T | ¥509B |
| Mar 2020 | ¥3.29T | ¥3.19T | ¥100B |
| Mar 2019 | ¥2.10T | ¥1.86T | ¥238B |
| Mar 2018 | ¥1.77T | ¥1.53T | ¥242B |
| Mar 2017 | ¥1.73T | ¥1.58T | ¥156B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.